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Abstract
AIM—To describe cerebral palsy (CP) surveillance programmes and identify similarities and 
differences in governance and funding, aims and scope, definition, inclusion/exclusion criteria, 
ascertainment and data collection, to enhance the potential for research collaboration.
METHOD—Representatives from 38 CP surveillance programmes were invited to participate in 
an online survey and submit their data collection forms. Descriptive statistics were used to 
summarize information submitted.
RESULTS—Twenty-seven surveillance programmes participated (25 functioning registers, two 
closed owing to lack of funding). Their aims spanned five domains: resource for CP research, 
surveillance, aetiology/prevention, service planning, and information provision (in descending 
order of frequency). Published definitions guided decision making for the definition of CP and 
case eligibility for most programmes. Consent, case identification, and data collection methods 
varied widely. Ten key data items were collected by all programmes and a further seven by at least 
80% of programmes. All programmes reported an interest in research collaboration.
INTERPRETATION—Despite variability in methodologies, similarities exist across programmes 
in terms of their aims, definitions, and data collected. These findings will facilitate harmonization 
of data and collaborative research efforts, which are so necessary on account of the heterogeneity 
and relatively low prevalence of CP.
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Cerebral palsy (CP) is a heterogeneous neurological condition with many aetiologies. 
Population-based surveillance programmes are considered the criterion standard for 
describing its changing birth and childhood prevalence and characteristics.1,2 The earliest 
CP registers and surveillance systems have reported on trends since the 1950s.1,3 However, 
the number of registers and population-based surveillance systems (hereafter referred to as 
‘surveillance programmes’) is increasing3 and currently nearly 40 exist worldwide.
Current collaborations between CP surveillance programmes that are geographically close 
allow not only comparisons between CP birth year cohorts but also pooling of data and 
greater statistical power for subgroup analyses. The first large network of CP surveillance 
programmes, the Surveillance of Cerebral Palsy in Europe (SCPE), was formed in 1998,4 
followed by the Autism and Developmental Disabilities Monitoring (ADDM) CP Network 
in the USA in 2002,5 and the Australian Cerebral Palsy Register (ACPR) in 2008.6 
Collaborating internationally across even broader geographical areas would further facilitate 
specific subgroup research—a necessity for CP.4
The purpose of this survey was to describe CP surveillance programmes and identify 
similarities and differences across topics of importance for the relevance and sustainability 
of, and collaboration between, surveillance programmes. It is anticipated that results will (1) 
encourage and inform those establishing new programmes about the methods and data items 
collected by existing programmes; (2) inform health professionals and researchers of the 
existence of national and international surveillance programmes and the potential for 
population-based research and data linkages; and (3) assist existing surveillance programmes 
to investigate the potential for future collaborations.
METHOD
Representatives from 38 surveillance programmes were contacted by e-mail and invited to 
participate in the online survey. Surveillance programmes were identified by the study 
authors, and all participants were encouraged to forward the survey link to any other known 
surveillance programmes.
The survey, developed and constructed by the study authors, was available online via 
‘Survey Monkey’ (https://www.surveymonkey.com) for 4 weeks in June to July 2014. 
Seventy-one questions related to issues of governance and funding, aims and scope, 
definition of CP, inclusion/exclusion criteria, ascertainment strategies, data collected, and 
research collaboration. A variety of question formats were used including open-ended and 
multiple choice. Participants were asked to supply a copy of their data collection sheet in 
English and a list of publications arising from their surveillance programmes. Non-
responders to the initial invitation were prompted to participate one further time by e-mail.
Given the negligible risk posed by the survey, exemption from ethical review was approved 
by the Cerebral Palsy Alliance Ethics Committee, a recognized National Health and Medical 
Research Council Human Research Ethics Committee (EC 00402). Informed consent of the 
participants was implied by survey completion. Participants were contacted by e-mail if 
clarification was required on specific responses.
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Descriptive statistics were generated throughout. For questions with response rates of at least 
80%, relative frequencies (percentages) are reported. Absolute frequencies (raw counts) are 
otherwise reported. Inductive content analysis was used to analyse the qualitative data from 
open-ended questions. For items where multiple responses were possible, percentages can 
exceed 100%.
RESULTS
Twenty-seven surveillance programmes participated (response rate 71%), including three 
collaborations between surveillance programmes (SCPE, ADDM, ACPR). Participants 
represented 11 countries and three geographical regions (Australia, Europe, and North 
America). Two surveillance programmes reported that they have ceased operation in recent 
years owing to lack of funding. Non-responders included 10 European programmes and one 
programme from Australasia. All further results refer to the 25 operating programmes. 
Programmes varied greatly in the birth years included. The earliest data available are from 
the birth year 1954 (Table I). See the full report of this survey available online for detailed 
results and the full original survey (http://impact.cerebralpalsy.org.au/activities/research-
activities/cp-register-and-surveillance).
Aims
There was considerable common ground about the aims of surveillance programmes, and 
most reported multiple aims. Responses could be grouped in five key domains: (1) resource 
for CP research (100%), for example identifying potential subjects, identifying CP as a long 
term outcome, and gauging representativeness of study samples; (2) surveillance (92%), for 
example monitoring prevalence, time trends, or survival by key characteristics; (3) 
prevention (68%), for example identifying aetiological pathways and reporting prevalence 
over time with the introduction of preventive strategies; (4) planning (48%), for example 
assisting with the planning of services for people with CP; (5) provide information about CP 
(20%), for example raising community awareness.
Definition
Five definitions of CP were used, with 46% of surveillance programmes using more than 
one definition. The SCPE definition was most cited (63%),4 followed by that of Rosenbaum 
et al. 2007 (54%).7
Denominators
There was significant variability in demographic criteria determining eligibility (where they 
were born, where they currently reside, where their family resided at time of birth), with 
many programmes using multiple criteria. Denominators reported included live births 
(78%), children living in area at a specified age (35%), neonatal survivors (26%), 1 year 
survivors (9%), with some programmes having access to more than one denominator.
Funding
Funding for surveillance programmes was received from the government (health/education/
research) (72%), not for profit/charitable organizations (12%), and other external sources 
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(12%). Some groups reported multiple funding sources and one programme received no 
specific funding for CP surveillance activities.
Eligibility
To help improve precision in identification of cases, 55% of programmes used either of the 
papers by Badawi et al.8 or Smithers-Sheedy et al.,9 and 45% of surveillance programmes 
used the SCPE definition and decision tree.4
Surveillance programmes were specifically asked about several eligibility issues that have 
historically varied between programmes. Variation was still seen, with 44% of programmes 
stipulating a minimum age of survival (Table I) and 46% reporting minimum severity criteria 
for inclusion. Although 96% of programmes included, but differentiated, postneonatally 
acquired CP cases, the upper age limit varied for timing of postneonatally acquired brain 
injury (Table I). Hypotonic CP was included in 54% of programmes, all based outside 
Europe, and was not consistently defined. Criteria for inclusion as hypotonic CP used by the 
ADDM Network in the USA included ‘hypotonia’ and meeting ADDM criteria for CP or a 
diagnosis of ‘hypotonic CP’ made by a qualified examiner, for example a paediatric 
neurologist or developmental paediatrician. A review of cases of hypotonic CP as part of the 
ADDM Network was recently undertaken and the results are forthcoming.
Consent requirements and methods used to identify new cases
The consent requirements for collecting, recording, and maintaining the data set varied 
across surveillance programmes (Table I). Some surveillance programmes received 
permission from a government body, usually a health or education authority, whereas other 
programmes required individual/parent permission/consent. Several surveillance 
programmes used a combination of consent methods, each addressing different activities of 
the programme (Table I). Most (80%) surveillance programmes had provisions for allowing 
contact with registered individuals to invite them to participate in future research activities.
Many different methods were used to identify new cases, with 68% of surveillance 
programmes using four or more different methods and 84% using five or more different data 
sources (Table II). Medical professionals were the most commonly reported source of data 
(100%).
Data collection
Age at data collection varied greatly between the surveillance programmes, ranging from 
birth/first diagnosis to older adulthood, depending on the programme’s purpose and 
geographical region. Ascertainment was generally considered complete between 5 and 8 
years of age. Forty-six per cent of surveillance programmes had a procedure for assessing 
the completeness of population ascertainment. Six programmes reported comparing rates 
with long-standing population surveillance programmes anticipated to have similar rates of 
CP, three compared with other surveillance programmes/health care sources, and two used 
capture–recapture techniques: however, short of house-to-house surveys,10 there was no 
criterion standard.
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Classification of CP subtypes
Significant geographical variation existed in classification of CP based on the type/s and 
topographical pattern of the movement disorder, reflecting the different definitions used for 
CP. Within spastic CP subtypes, all European programmes used as a minimum ‘unilateral’ 
and ‘bilateral’ to classify topography. In Australia, monoplegia/hemiplegia/diplegia/
triplegia/quadriplegia were used consistently, which can be grouped to match European 
categories when required. Most North American programmes used both systems.
Aetiology
Eighty-seven per cent of surveillance programmes collected information about aetiology of 
cases not postneonatally acquired, with many collecting this as free-text.
Congenital anomalies
Seventy-five per cent of programmes collected data on congenital anomalies, most 
categorizing by International Statistical Classification of Diseases and Related Health 
Problems 10th Revision (ICD-10) codes and/or free text. The upper age limit for recognition 
of congenital anomalies varied from at birth to no restriction. Sixty-seven per cent of 
programmes reported that a congenital anomalies register existed serving the same 
population as their CP surveillance programme; seven programmes had performed linkages 
with these registers.
Cerebral imaging
All programmes collected either (1) whether imaging had been performed (79%, of which 
63% recorded where imaging was performed), and/or (2) clinical reports of imaging findings 
(54%), and/or (3) the original images (13%). Ninety-six per cent of all programmes 
collected data pertaining to cranial magnetic resonance imaging (MRI), 67% to cranial 
ultrasound, and 54% to cranial computed tomography.
Fourteen programmes reported the imaging classification system used by their surveillance 
programme to interpret and record images; seven programmes had not yet adopted a formal 
classification system. Seven programmes classified imaging based on clinical reports of 
neuroimaging findings, one programme classified scans by re-reading original images, and 
three used a combination of reports and rereading images. Imaging was classified by more 
than one person for seven programmes, and usually by a single person for three 
programmes. Classifications were made by a broad range of medical professionals 
(radiologist, neuropaediatrican, paediatric neurologist, neuroradiologist, paediatrician, 
paediatric neuroradiologist), other clinicians, and by surveillance programme staff.
Multiple births
Ninety-two per cent of programmes collected information on the plurality of the pregnancy, 
and 88% collected birth order. Only a few surveillance programmes systematically collected 
information on death of a co-multiple at <20 weeks’ gestation (17%), death of a co-multiple 
at >20 weeks’ gestation (17%), timing of death of a co-multiple (13%), health outcome of 
co-multiples (13%), zygosity (13%), or chorionicity/amnionicity (8%). Seventy-three per 
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cent did not consider a survivor as a multiple if their comultiple(s) died before 20 weeks’ 
gestation.
Assisted conception
Fifty-five per cent of programmes recorded some aspect of assisted conception, with most 
recording whether in vitro fertilization was used for the pregnancy.
Follow-up after verification
Twenty-one per cent of programmes systematically completed follow-up of children after 
they had been verified as having CP. Age at follow-up and frequency varied widely, from 
annually, to 5 years, 10 years, and/or at 15 to 17 years of age.
Interventions
Seventy-two per cent of programmes collected information on interventions received, 
including surgeries (56%), spasticity medications (48%), assistive devices (including 
orthotics and equipment) (48%), and therapies (36%). Four programmes had a longitudinal 
follow-up programme for secondary impairment prevention (CPUP Sweden, Danish 
National Cerebral Palsy Register, The Cerebral Palsy Register of Norway, NSW and ACT 
Cerebral Palsy Register Australia).
Data sheets
Data collection forms were available for 22 operating programmes. Overall, 38 items were 
collected by at least half of the programmes, with 10 collected by all programmes. Six of 
these items were collected in the same way across programmes. It was clear that there was 
some common ground for key data items but also considerable variation in additional data 
items and methods of collection (Table III).
Research collaboration
All programmes reported an interest in collaborating with other surveillance programmes. 
Forty-eight per cent of programmes have had a linkage/collaborative relationship with other 
surveillance programmes serving the same denominator group for research purposes, for 
example perinatal data sets/newborn quality register, regional and national death indexes, 
intervention services/health databases, congenital anomalies registry, CP follow-up program. 
Sixty-seven per cent reported a linkage/collaborative relationship with similar CP 
surveillance programmes serving other denominator groups.
Eighty per cent of programmes were able to send ad hoc, de-identified individual data to be 
used in collaborative studies with appropriate ethics approval. Thirty-three per cent had 
access to controls through a variety of methods including national health care registers, 
sampling of birth certificates, and as invited study participants.
Current research themes being investigated by the surveillance programmes included 
aetiology (68%), participation (48%), evaluation of interventions (40%), and survival (32%). 
Fifty-two per cent of programmes reported trends that they would like to discuss with other 
programmes, such as the decrease in birth prevalence of CP in extremely preterm infants, 
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increase in the proportion of unilateral CP, and the increase in the proportion of hypotonic 
CP, all of which were reported by more than one programme.
DISCUSSION
CP surveillance programmes, like the people with CP that they represent, are heterogeneous. 
Although differences in methodologies existed across various geographical regions, there 
was some consistency in aims, definitions, and data sets. Some differences in important 
areas such as inclusion/exclusion criteria have recently been reported in the paper by 
Smithers-Sheedy et al.9 and this survey confirmed those findings.
Although several data items were collected by the majority of programmes, the manner in 
which each was collected was not always comparable, particularly for items referring to 
aetiological risk factors, neonatal history, and associated impairments. For example, 34 
different data items referring to vision were used across the data collection forms received. 
Professionals working with surveillance programmes need to decide if these common data 
elements are sufficiently important to warrant taking further steps to facilitate harmonization 
internationally. Himmelmann and colleagues recommended that the collection of CP register 
data be updated in line with emerging knowledge in the field,2 but meeting this proposal 
may have implications for the identification of time trends. In the future, systematic 
collection of biomarker data or linkage with existing bio-banks (e.g. genetic testing and 
placental pathology) will be important. Additionally, extending systematic collection of data 
related to comorbidities, functioning, participation, and management into middle childhood, 
adolescence, and adulthood would extend our understanding of the breadth of the condition 
on a population basis across the lifespan.
The publication of the Gross Motor Function Classification System (GMFCS)11 in 1997 
represented a new era in the classification of gross motor function in CP. It is encouraging 
that all current surveillance programmes are using the GMFCS (Table III). On the other 
hand, geographical differences exist in classification systems for upper limb function, with 
most Australian and North American programmes using the Manual Ability Classification 
System (MACS), and European programmes using the Bimanual Fine Motor Function 
classification.12,13 Classification systems for communication, speech, and dysphagia are not 
in universal use, although potentially useful classifications have recently been 
developed.14–17 Working towards valid and reliable classification systems and incorporating 
these into surveillance programmes over time is essential to allow (1) comparison with data 
from other programmes and (2) monitoring the severity of CP over time.
Where numbers of cases are small, collaborative research efforts are of paramount 
importance. All participating CP surveillance programmes reported an interest in 
collaborating with other programmes and, with ethics approval, most (80%) were able to 
provide ad hoc, de-identified individual data. Barriers to collaboration identified by survey 
respondents included funding difficulties, problems with harmonization and comparability 
of data (definition, inclusion/exclusion criteria), and with negotiating common ground and 
priorities for research. International collaborative research networks such as IMPACT for 
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Cerebral Palsy (International Multidisciplinary Prevention and Cure Team) have been 
established to further encourage collaboration between groups.
Although systematic reviews and randomized controlled trials of interventions are 
considered the ‘criterion standard’ for evaluating effectiveness of interventions, surveillance 
programmes also have a role, particularly for heterogeneous conditions such as CP. Four 
surveillance programmes included an individual, longitudinal follow-up programme aiming 
to prevent secondary impairments. Such programmes have been shown to significantly 
decrease musculoskeletal complications such as hip dislocation,18,19 and some are 
expanding to include functional outcomes across domains including communication, 
mobility, self-care, and social interaction.20,21 Surveillance programmes are also vital for 
evaluating the ‘real world’ outcomes of new interventions deemed effective in research 
settings.
It was not considered valid to report a combined prevalence of CP calculated across 
surveillance programmes because of the variability in methods of obtaining those estimates. 
Variations in estimated prevalence across surveillance programmes are considered to be at 
least partly accounted for by methodological differences (such as inclusion criteria, 
particularly whether postneonatally acquired cases are included, minimum age of survival, 
consent requirements, and type of denominator). The length of time a surveillance 
programme has been operating is also an important determinant. After commencement, it 
takes some years to build ascertainment as surveillance programme workers increase 
knowledge of locally appropriate ascertainment techniques and both medical and affected 
communities become aware of the existence of the surveillance programme. It is possible 
that variations in proportion reported with CP are due primarily to methodological 
differences and resulting variations in ascertainment proportion rather than to underlying 
differences in prevalence of the condition. Time trends should therefore only be assessed 
from proportions estimated by the same methods over time.22
This survey had several limitations. Although attempts were made to identify and invite all 
known CP surveillance programmes, there are at least 11 currently operating programmes 
that did not participate, and a further three did not contribute their data collection forms. The 
programmes that did participate were mostly based in Europe and Australia, and developing 
countries are not represented. Although this may represent a true lack of surveillance 
programmes in developing countries,3 relevant studies and surveys are known to have been 
completed in such countries.23,24 As the prevalence and aetiological profile of CP are known 
to vary by socioeconomic status,25 as well as by perinatal care conditions (e.g. preterm 
birth), this presents an important area for future research. This survey did not address the 
topic of participant/parent involvement in the functioning of surveillance programmes. 
Although beyond the scope of this survey, we are aware of multiple programmes across 
Europe and Australia that have participant/parent advisory groups informing the work of the 
CP surveillance programme.
Two surveillance programmes have closed in recent years owing to lack of funding, 
highlighting the continuing difficulties programmes face in a global climate of financial 
constraints. In this era of increased research into the possibilities for prevention of CP and 
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achieving better outcomes for those with CP, surveillance programmes will play a vital role 
in the pragmatic evaluation of treatments that have been found to be efficacious or effective 
in a research setting. It is important that existing programmes are able to report not only 
trends in prevalence but also severity, and compare these across different geographical 
regions, particularly those that differ in their approaches to perinatal care and CP 
management.
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What this paper adds
• CP surveillance programmes aim to be a resource for research and surveillance.
• Methods vary significantly, however all surveillance programmes are committed 
to collaboration.
• Seventeen core data items identified should be included in new surveillance 
programmes.
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Disability service providers 19
Hospital inpatient records 19
Hospital outpatient records 17





Routine child health surveillance 9
Diagnostic registers 7
Midwives data system 7
Education records 6
Research partnerships 4
Morbidity data system 3
Health visitors 1
Tax register 1
Other: for example prospective registrations
  within secondary prevention programme,
  administrative organization providing
  funding to families, disability financial
  support providers, administrative local
  authority for children with disabilities,
  website
8
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Table III





  by ≥80% of
  programmes
Items collected
  by ≥50% of
  programmes
Date of birtha Vision Number previous live
  births/stillbirths to mother
Sexa Hearing Order of birth (multiple
  births)




GMFCSa Mother’s year of
  birth/age at
  delivery
Aetiology of main
  deficiency if known
Diagnosis/motor
  type





  and expression
Age/date at diagnosis










  of parents
Strabismus
Cranial ultrasound in
  neonatal period
Drug treatment for hypertonia
Paediatrician/health









Data item collected in same way across all surveillance programmes.
b
If included in surveillance programme. NICU, neonatal intensive care unit; SCN, special care nursery; GMFCS, Gross Motor Function 
Classification System; MACS, Manual Ability Classification System.
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